Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet

다국어 초록 (Multilingual Abstract)

The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase due to the diabetes epidemic and its early and widespread appearance. CAN has a definite prognostic role for mortality and cardiovascular morbidity. Putative mechanisms for this are tachycardia, QT interval prolongation, orthostatic hypotension, reverse dipping, and impaired heart rate variability, while emerging mechanisms like inflammation support the pervasiveness of autonomic dysfunction. Efforts to overcome CAN under-diagnosis are on the table: by promoting screening for symptoms and signs; by simplifying cardiovascular reflex tests; and by selecting the candidates for screening. CAN assessment allows for treatment of its manifestations, cardiovascular risk stratification, and tailoring therapeutic targets. Risk factors for CAN are mainly glycaemic control in type 1 diabetes mellitus (T1DM) and, in addition, hypertension, dyslipidaemia, and obesity in type 2 diabetes mellitus (T2DM), while preliminary data regard glycaemic variability, vitamin B12 and D changes, oxidative stress, inflammation, and genetic biomarkers. Glycaemic control prevents CAN in T1DM, whereas multifactorial intervention might be effective in T2DM. Lifestyle intervention improves autonomic function mostly in pre-diabetes. While there is no conclusive evidence for a disease-modifying therapy, treatment of CAN manifestations is available. The modulation of autonomic function by SGLT2i represents a promising research field with possible clinical relevance.

참고문헌 (Reference)

• 1 Gaede P, "Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria : 21 years follow-up on the Steno-2 randomised trial" 59 : 2298-2307, 2016
• 2 Maser RE, "Vitamin D insufficiency is associated with reduced parasympathetic nerve fiber function in type 2 diabetes" 21 : 174-181, 2015
• 3 Hansen CS, "Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes" 31 : 202-208, 2017
• 4 Greco C, "Validation of the Composite Autonomic Symptom Score 31(COMPASS 31)for the assessment of symptoms of autonomic neuropathy in people with diabetes" 34 : 834-838, 2017
• 5 Spallone V, "Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients" 21 : 381-386, 2007
• 6 DiBona GF, "Translational medicine : the antihypertensive effect of renal denervation" 298 : R245-R253, 2010
• 7 Guarino D, "The role of the autonomic nervous system in the pathophysiology of obesity" 8 : 665-, 2017
• 8 Stein PK, "The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome : the Cardiovascular Health Study" 24 : 855-863, 2007
• 9 Jung CH, "The relationship between vitamin D status and cardiac autonomic neuropathy in patients with type 2 diabetes mellitus" 12 : 342-351, 2015
• 10 Annuzzi G, "The relationship between blood glucose concentration and beat-to-beat variation in asymptomatic subjects" 20 : 57-62, 1983
• 11 Gibbons CH, "The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension" 264 : 1567-1582, 2017
• 12 Akbari M, "The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases : a systematic review and meta-analysis of randomized controlled trials" 87 : 56-69, 2018
• 13 Jordan J, "The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus" 11 : 604-612, 2017
• 14 Baggio LL, "The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice" 6 : 1339-1349, 2017
• 15 Jun JE, "The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes" 14 : 70-, 2015
• 16 Yun JS, "The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study" 108 : 31-37, 2015
• 17 Carnethon MR, "The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program" 29 : 914-919, 2006
• 18 Rossen NB, "Targeting nocturnal hypertension in type 2 diabetes mellitus" 64 : 1080-1087, 2014
• 19 Rajan S, "Sudomotor function testing by electrochemical skin conductance : does it really measure sudomotor function" 29 : 31-39, 2019
• 20 Ang L, "Sudomotor dysfunction as a measure of small fiber neuropathy in type 1 diabetes" 205 : 87-92, 2017
• 21 Pennathur S, "Structured lifestyle intervention in patients with the metabolic syndrome mitigates oxidative stress but fails to improve measures of cardiovascular autonomic neuropathy" 31 : 1437-1443, 2017
• 22 Associazione Medici Diabetologi, "Standard italiani per la cura del diabete mellito 2018"
• 23 Pafili K, "Simplified diagnosis of cardiovascular autonomic neuropathy in type 2 diabetes using Ewing’s battery" 12 : 213-219, 2015
• 24 Selvarajah D, "SUDOSCAN : a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy" 10 : e0138224-, 2015
• 25 Matthews VB, "Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2" 35 : 2059-2068, 2017
• 26 Andersen ST, "Risk factors for the presence and progression of cardiovascular autonomic neuropathy in type 2 diabetes : ADDITION-Denmark" 41 : 2586-2594, 2018
• 27 Dimova R, "Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance" 31 : 537-543, 2017
• 28 Hillis GS, "Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus" 55 : 1283-1290, 2012
• 29 Aune D, "Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality : a systematic review and dose-response meta-analysis of prospective studies" 27 : 504-517, 2017
• 30 김선희, "Relationship between the Korean Version Survey of the Autonomic Symptoms Score and Cardiac Autonomic Neuropathy Parameters in Patients with Diabetic Peripheral Neuropathy" 대한당뇨병학회 38 (38): 349-355, 2014
• 31 Soedamah-Muthu SS, "Relationship between risk factors and mortality in type 1 diabetic patients in Europe : the EURODIAB Prospective Complications Study(PCS)" 31 : 1360-1366, 2008
• 32 Kalopita S, "Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes" 2014 : 835392-, 2014
• 33 Weinrauch LA, "Relationship between autonomic function and progression of renal disease in diabetic proteinuria : clinical correlations and implications for blood pressure control" 11 : 302-308, 1998
• 34 Spallone V, "Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy" 21 : 69-78, 2011
• 35 Whitsel EA, "Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes : a meta-analysis" 23 : 241-247, 2000
• 36 Spallone V, "Reappraisal of the diagnostic role of orthostatic hypotension in diabetes" 19 : 58-64, 2009
• 37 Salles GF, "Prognostic effect of the nocturnal blood pressure fall in hypertensive patients : the ambulatory blood pressure collaboration in patients with hypertension(ABC-H)meta-analysis" 67 : 693-700, 2016
• 38 Fujimoto WY, "Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance" 36 : 730-739, 1987
• 39 Zoppini G, "Prevalence of cardiovascular autonomic neuropathy in a cohort of patients with newly diagnosed type 2 diabetes : the Verona Newly Diagnosed Type 2 Diabetes Study(VNDS)" 38 : 1487-1493, 2015
• 40 Ziegler D, "Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial" 30 : 350-356, 2016
• 41 Tannus LR, "Predictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes" 5 : 191-, 2014
• 42 Hansen TW, "Predictive role of the nighttime blood pressure" 57 : 3-10, 2011
• 43 England JD, "Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation" 72 : 177-184, 2009
• 44 Sauder KA, "Pistachio nut consumption modifies systemic hemodynamics, increases heart rate variability, and reduces ambulatory blood pressure in well-controlled type 2 diabetes : a randomized trial" 3 : e000873-, 2014
• 45 Ghezzi C, "Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2" 61 : 2087-2097, 2018
• 46 Chung JO, "Physiological serum bilirubin concentrations are inversely associated with the prevalence of cardiovascular autonomic neuropathy in patients with type 2 diabetes" 31 : 185-191, 2014
• 47 Villafaina S, "Physical exercise improves heart rate variability in patients with type 2 diabetes : a systematic review" 17 : 110-, 2017
• 48 Tahrani AA, "Peripheral and autonomic neuropathy in south Asians and white Caucasians with type 2 diabetes mellitus : possible explanations for epidemiological differences" 2017 : 1273789-, 2017
• 49 Ziegler D, "Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients" 52 : 65-72, 2015
• 50 Fleg JL, "Orthostatic hypotension in the ACCORD(Action to Control Cardiovascular Risk in Diabetes)blood pressure trial : prevalence, incidence, and prognostic significance" 68 : 888-895, 2016
• 51 Casiglia E, "Orthostatic hypotension : new views for an old problem" 35 : 947-949, 2017
• 52 Phillip A. Low, "Orthostatic Hypotension: Mechanisms, Causes, Management" 대한신경과학회 11 (11): 220-226, 2015
• 53 Shaw BH, "Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a ‘sit-to-stand test’" 35 : 1019-1025, 2017
• 54 Greco C, "Obstructive sleep apnoea syndrome and diabetes. Fortuitous association or interaction?" 12 : 129-155, 2015
• 55 Hjortkjaer HO, "Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping : a randomised, placebo-controlled, double-blind cross-over trial" 6 : e012307-, 2016
• 56 Martin CL, "Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study" 37 : 31-38, 2014
• 57 Spallone V, "Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy" 26 : 686-692, 2009
• 58 Sjoberg N, "Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes" 110 : 1060-1064, 2011
• 59 Bernardi L, "Methods of investigation for cardiac autonomic dysfunction in human research studies" 27 : 654-664, 2011
• 60 Burger AJ, "Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy" 86 : 281-287, 2002
• 61 Athyros VG, "Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy" 53 : 201-209, 1998
• 62 Cacciatori V, "Long-acting GLP-1 receptor agonist exenatide influence on the autonomic cardiac sympatho-vagal balance" 2 : 53-62, 2017
• 63 Bernardi L, "Integrated cardio-respiratory control : insight in diabetes" 16 : 107-, 2016
• 64 Valensi P, "Insulin-and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity : why they matter" 56 : 1196-1200, 2013
• 65 Hermida RC, "Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes" 34 : 1270-1276, 2011
• 66 Alam I, "Influence of bariatric surgery on indices of cardiac autonomic control" 151 : 168-173, 2009
• 67 Herder C, "Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes" 103 : 63-70, 2017
• 68 Ziegler D, "Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population : the KORA S4 survey" 58 : 1118-1128, 2015
• 69 Kokkinos A, "Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity" 23 : 31-38, 2013
• 70 Di Flaviani A, "Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients" 34 : 1605-1609, 2011
• 71 Chilton R, "Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension" 19 : 1620-1624, 2017
• 72 Charles M, "Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes : ADDITION-Denmark, a cluster-randomised study" 56 : 101-108, 2013
• 73 Sun F, "Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes : a systematic review and network meta-analysis" 110 : 26-37, 2015
• 74 Hansen CS, "High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with type 1 and type 2 diabetes" 34 : 364-371, 2017
• 75 Brotman DJ, "Heart rate variability predicts ESRD and CKD-related hospitalization" 21 : 1560-1570, 2010
• 76 Klimontov VV, "Heart rate variability is associated with interstitial glucose fluctuations in type 2 diabetic women treated with insulin" 5 : 337-, 2016
• 77 Fleischer J, "Glycemic variability is associated with reduced cardiac autonomic modulation in women with type 2 diabetes" 38 : 682-688, 2015
• 78 Xu W, "Glycemic variability is an important risk factor for cardiovascular autonomic neuropathy in newly diagnosed type 2 diabetic patients" 215 : 263-268, 2016
• 79 Siegelaar SE, "Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes : data from the DCCT" 52 : 2229-2232, 2009
• 80 Gerritsen J, "Glucose tolerance and other determinants of cardiovascular autonomic function : the Hoorn Study" 43 : 561-570, 2000
• 81 Yamamoto H, "Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons" 110 : 43-52, 2002
• 82 Hansen AL, "Fish consumption, sleep, daily functioning, and heart rate variability" 10 : 567-575, 2014
• 83 Abbott CA, "Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans" 33 : 1325-1330, 2010
• 84 Loimaala A, "Exercise training improves baroreflex sensitivity in type 2 diabetes" 52 : 1837-1842, 2003
• 85 Bhati P, "Exercise training and cardiac autonomic function in type 2 diabetes mellitus : a systematic review" 12 : 69-78, 2018
• 86 Voulgari C, "Exercise improves cardiac autonomic function in obesity and diabetes" 62 : 609-621, 2013
• 87 Smits MM, "Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males" 81 : 613-620, 2016
• 88 Zhao P, "Evening versus morning dosing regimen drug therapy for hypertension" 10 : CD004184-, 2011
• 89 Isak B, "Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance" 24 : 563-569, 2008
• 90 Gupta R, "Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities" 8 : 470-482, 2016
• 91 Wu JS, "Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose" 92 : 3885-3889, 2007
• 92 Novak P, "Electrochemical skin conductance : a systematic review" 29 : 17-29, 2019
• 93 Hu X, "Efficacy and safety of aldose reductase inhibitor for the treatment of diabetic cardiovascular autonomic neuropathy : systematic review and meta-analysis" 9 : e87096-, 2014
• 94 Ebbehoj E, "Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria" 45 : 965-975, 2002
• 95 Pop-Busui R, "Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes : a randomised controlled trial" 56 : 1835-1844, 2013
• 96 Ziegler D, "Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie" 20 : 369-373, 1997
• 97 Maser RE, "Effects of surgically induced weight loss by Roux-en-Y gastric bypass on cardiovascular autonomic nerve function" 9 : 221-226, 2013
• 98 Kumarathurai P, "Effects of liraglutide on heart rate and heart rate variability : a randomized, double-blind, placebo-controlled crossover study" 40 : 117-124, 2017
• 99 Bharucha AE, "Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans" 295 : R874-R880, 2008
• 100 Pop-Busui R, "Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes(ACCORD)trial" 33 : 1578-1584, 2010
• 101 Saboori S, "Effects of alpha-lipoic acid supplementation on C-reactive protein level : a systematic review and meta-analysis of randomized controlled clinical trials" 28 : 779-786, 2018
• 102 Bellavere F, "Effects of aerobic or resistance exercise training on cardiovascular autonomic function of subjects with type 2 diabetes : a pilot study" 28 : 226-233, 2018
• 103 이솔재, "Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea" 대한당뇨병학회 41 (41): 275-283, 2017
• 104 Nakatani Y, "Effects of GLP-1 receptor agonists on heart rate and the autonomic nervous system using holter electrocardiography and power spectrum analysis of heart rate variability" 39 : e22-e23, 2016
• 105 Maser RE, "Effect of treatment with losartan on cardiovascular autonomic and large sensory nerve fiber function in individuals with diabetes mellitus : a 1-year randomized, controlled trial" 17 : 286-291, 2003
• 106 Didangelos TP, "Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy" 20 : 1-7, 2006
• 107 Ziegler D, "Effect of low-energy diets differing in fiber, red meat, and coffee intake on cardiac autonomic function in obese individuals with type 2 diabetes" 38 : 1750-1757, 2015
• 108 Kubba S, "Effect of losartan on albuminuria, peripheral and autonomic neuropathy in normotensive microalbuminuric type 2 diabetics" 51 : 355-358, 2003
• 109 Kontopoulos AG, "Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy" 20 : 355-361, 1997
• 110 Malik RA, "Effect of angiotensin-converting-enzyme(ACE)inhibitor trandolapril on human diabetic neuropathy : randomised double-blind controlled trial" 352 : 1978-1981, 1998
• 111 Rahman A, "Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats" 44 : 522-525, 2017
• 112 Rosengard-Barlund M, "Early autonomic dysfunction in type 1 diabetes : a reversible disorder" 52 : 1164-1172, 2009
• 113 Spallone V, "Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric type 2 diabetic patients" 21 : 1174-1180, 2004
• 114 Pop-Busui R, "Diabetic neuropathy : a position statement by the American Diabetes Association" 40 : 136-154, 2017
• 115 Tesfaye S, "Diabetic neuropathies : update on definitions, diagnostic criteria, estimation of severity, and treatments" 33 : 2285-2293, 2010
• 116 Cha SA, "Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes" 11 : e0164807-, 2016
• 117 Vinik AI, "Diabetic cardiovascular autonomic neuropathy" 115 : 387-397, 2007
• 118 Schroeder EB, "Diabetes, glucose, insulin, and heart rate variability : the Atherosclerosis Risk in Communities(ARIC)study" 28 : 668-674, 2005
• 119 Golbidi S, "Diabetes and alpha lipoic acid" 2 : 69-, 2011
• 120 Fagard RH, "Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension" 51 : 55-61, 2008
• 121 Tavakoli M, "Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy" 52 : 363-370, 2015
• 122 Fleischer J, "Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy" 31 : 1389-1393, 2017
• 123 Freeman R, "Consensus statement on the definition of orthostatic hypotension, neutrally mediated syncope and the postural tachycardia syndrome" 21 : 69-72, 2011
• 124 Fanciulli A, "Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society(AAS)and the European Federation of Autonomic Societies(EFAS) : Endorsed by the European Academy of Neurology(EAN)and the European Society of Hypertension(ESH)" 28 : 355-362, 2018
• 125 Ciccacci C, "Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes" 51 : 663-671, 2014
• 126 Cuspidi C, "Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: an updated review" 19 : 713-721, 2017
• 127 Perciaccante A, "Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus" 6 : 19-, 2006
• 128 Manzella D, "Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes" 73 : 1052-1057, 2001
• 129 Ribeiro MJ, "Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets" 62 : 2905-2916, 2013
• 130 Ricci F, "Cardiovascular morbidity and mortality related to orthostatic hypotension : a meta-analysis of prospective observational studies" 36 : 1609-1617, 2015
• 131 Fleischer J, "Cardiovascular autonomic neuropathy is associated with macrovascular risk factors in type 2 diabetes : new technology used for routine large-scale screening adds new insight" 8 : 874-880, 2014
• 132 Spallone V, "Cardiovascular autonomic neuropathy in diabetes : clinical impact, assessment, diagnosis, and management" 27 : 639-653, 2011
• 133 Nyiraty S, "Cardiovascular autonomic neuropathy and glucose variability in patients with type 1 diabetes: is there an association?" 9 : 174-, 2018
• 134 Pop-Busui R, "Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications(DCCT/EDIC)study" 40 : 94-100, 2017
• 135 Yun JS, "Cardiovascular autonomic dysfunction predicts severe hypoglycemia in patients with type 2 diabetes : a 10-year follow-up study" 37 : 235-241, 2014
• 136 Laitinen T, "Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance" 28 : 699-704, 2011
• 137 Rohling M, "Cardiorespiratory fitness and cardiac autonomic function in diabetes" 17 : 125-, 2017
• 138 Young LH, "Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes : the DIAD study : a randomized controlled trial" 301 : 1547-1555, 2009
• 139 Tahrani AA, "Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes : a cohort study" 57 : 1249-1256, 2014
• 140 Astrup AS, "Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy" 29 : 334-339, 2006
• 141 Orlov S, "Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes" 10 : 1136-1144, 2015
• 142 김용균, "Cardiac Autonomic Neuropathy as a Predictor of Deterioration of the Renal Function in Normoalbuminuric, Normotensive Patients with Type 2 Diabetes Mellitus" 대한의학회 24 : 69-74, 2009
• 143 Sletten DM, "COMPASS 31 : a refined and abbreviated Composite Autonomic Symptom Score" 87 : 1196-1201, 2012
• 144 Spallone V, "Blood pressure variability and autonomic dysfunction" 18 : 137-, 2018
• 145 Manzella D, "Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients : effect of metformin administration" 17 : 223-227, 2004
• 146 Johansson BL, "Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus" 17 : 181-189, 2000
• 147 Tang ZH, "Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard" 4 : e005096-, 2014
• 148 Casellini CM, "Bariatric surgery restores cardiac and sudomotor autonomic c-fiber dysfunction towards normal in obese subjects with type 2 diabetes" 11 : e0154211-, 2016
• 149 Bellavere F, "Autonomic testing : which value for each cardiovascular test? An observational study" 56 : 39-43, 2019
• 150 Abboud FM, "Autonomic regulation of the immune system in cardiovascular diseases" 41 : 578-593, 2017
• 151 Sundkvist G, "Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM" 16 : 773-779, 1993
• 152 Tiftikcioglu BI, "Autonomic neuropathy and endothelial dysfunction in patients with impaired glucose tolerance or type 2 diabetes mellitus" 95 : e3340-, 2016
• 153 Lips MA, "Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies" 169 : 383-390, 2013
• 154 Maguire AM, "Autonomic nerve testing predicts the development of complications : a 12-year follow-up study" 30 : 77-82, 2007
• 155 Wulsin LR, "Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality" 100 : 2443-2448, 2015
• 156 Putz Z, "Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance" 30 : 358-362, 2013
• 157 Ziegler D, "Association of lower cardiovagal tone and baroreflex sensitivity with higher liver fat content early in type 2 diabetes" 103 : 1130-1138, 2018
• 158 Singh JP, "Association of hyperglycemia with reduced heart rate variability(The Framingham Heart Study)" 86 : 309-312, 2000
• 159 Lachin JM, "Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complications trial" 40 : 777-783, 2017
• 160 Ciccacci C, "Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes" 32 : 11-17, 2018
• 161 May O, "Assessing cardiovascular autonomic neuropathy in diabetes mellitus : how many tests to use" 14 : 7-12, 2000
• 162 Vinik AI, "American Association of Clinical Endocrinologists and American College of Endocrinology position statement on testing for autonomic and somatic nerve dysfunction" 23 : 1472-1478, 2017
• 163 Tankova T, "Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy(controlled, randomized, open-label study)" 42 : 457-464, 2004
• 164 Hansen CS, "Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function : Whitehall II study" 16 : 153-, 2017
• 165 Shibao C, "ASH position paper: evaluation and treatment of orthostatic hypotension" 15 : 147-153, 2013
• 166 Papanas N, "A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy" 30 : 525-534, 2013
• 167 Ge X, "A simple Chinese risk score model for screening cardiovascular autonomic neuropathy" 9 : e89623-, 2014
• 168 Forsen A, "A 14-year prospective study of autonomic nerve function in type 1 diabetic patients : association with nephropathy" 21 : 852-858, 2004
• 169 Tofe Povedano S, "24-Hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan" 11 : 426-431, 2009
• 170 Williams B, "2018 ESC/ESH guidelines for the management of arterial hypertension" 39 : 3021-3104, 2018